Related Experiment Video
Updated: Mar 7, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer
Xin Zhang1, Xiujuan Zhang1, Bo Yu1
1Department of Respiration, Liaocheng People's Hospital, Liaocheng, 252000, China.
Purpose:
We examined the epigenetic regulation of microRNA-137 (miR-137) on lysine-specific demethylase 1 (KDM1A, or LSD1) induced oncogenic effects in NSCLC.
Methods:
NSCLC cell lines, A549 and H460 cells were transfected with a mammalian LSD1 overexpression plasmid. It's effects on endogenous KDM1A gene and LSD1 protein expressions were examined by qRT-PCR and western blot assays. NSCLC proliferation and migration were also examined by MTT proliferation and wound-scratch assays, respectively. In LSD1-overexpeseed NSCLC cells, lentiviral transfection was conducted to upregulated miR-137 expression. The subsequent effects of miR-137 upregulation on LSD1-mediated cancer regulations were also examined. In addition, key components of histone deacetylases-associated signaling pathways, including EZH2, HDAC1 and HDAC2 were also examined by western blot in LSD1-and miR-137-mediated NSCLC cells.
Results:
Mammalian LSD1 overexpression plasmid was efficient in upregulating KDM1A gene and LSD1 protein in A549 and H460 cells. It also exerted oncogenic effects in NSCLC by promoting cancer proliferation and migration. MiR-137 was inversely correlated with LSD1 in NSCLC, as lentivirus-mediated miR-137 upregulation suppressed KDM1A/LSD1 productions and inhibited proliferation or migration in LSD1-overexpressed A549 and H460 cells. Further western blot analysis demonstrated EZH2, HDAC1 and HDAC2 were activated by LSD1, but inhibited by miR-137 in NSCLC.
Conclusion:
Oncogenic effects of LSD1 were reversely regulated by its upstream epigenetic modulator miR-137 in NSCLC. The interaction between LSD1 and miR-137 may very well involve the regulation on histone deacetylases-associated signaling pathways.
Insights
MicroRNA-137 (miR-137) epigenetically regulates lysine-specific demethylase 1 (LSD1) to suppress non-small cell lung cancer (NSCLC) growth. This study shows miR-137 reverses LSD1-induced oncogenic effects in NSCLC.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) exhibits complex epigenetic dysregulation.
- Lysine-specific demethylase 1 (KDM1A, also known as LSD1) is implicated in oncogenesis.
- MicroRNA-137 (miR-137) is a known tumor suppressor microRNA.
Purpose of the Study:
- To investigate the epigenetic regulation of microRNA-137 (miR-137) on lysine-specific demethylase 1 (LSD1) and its role in non-small cell lung cancer (NSCLC).
- To elucidate the mechanism by which miR-137 counteracts LSD1-induced oncogenic effects in NSCLC cells.
Main Methods:
- Overexpression of LSD1 in NSCLC cell lines (A549, H460) and assessment of its effects on cell proliferation and migration.
- Upregulation of miR-137 in LSD1-overexpressing NSCLC cells using lentiviral transfection.
- Analysis of KDM1A/LSD1 expression, proliferation, migration, and key histone deacetylase-associated pathway components (EZH2, HDAC1, HDAC2) via qRT-PCR and Western blot.
Main Results:
- LSD1 overexpression promoted NSCLC proliferation and migration by upregulating KDM1A and LSD1 protein.
- miR-137 upregulation inversely correlated with LSD1, suppressing KDM1A/LSD1 expression and inhibiting cancer cell proliferation and migration.
- LSD1 activated EZH2, HDAC1, and HDAC2, while miR-137 inhibited these targets in NSCLC cells.
Conclusions:
- Oncogenic effects of LSD1 in NSCLC are reversely regulated by its upstream epigenetic modulator, miR-137.
- The interaction between LSD1 and miR-137 likely involves the modulation of histone deacetylase-associated signaling pathways.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...